Federica Cavallo
Federica Cavallo
Full professor of Immunology, University of Torino, Italy
Verified email at unito.it
Cited by
Cited by
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
G Pelicci, L Lanfrancone, F Grignani, J McGlade, F Cavallo, G Forni, ...
Cell 70 (1), 93-104, 1992
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ...
The Journal of experimental medicine 188 (3), 589-596, 1998
Vaccines for tumour prevention
PL Lollini, F Cavallo, P Nanni, G Forni
Nature Reviews Cancer 6 (3), 204-216, 2006
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice
P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ...
The Journal of experimental medicine 194 (9), 1195-1206, 2001
2011: the immune hallmarks of cancer
F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini
Cancer Immunology, Immunotherapy 60 (3), 319-326, 2011
Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.
F Cavallo, M Giovarelli, A Gulino, A Vacca, A Stoppacciaro, A Modesti, ...
The Journal of Immunology 149 (11), 3627-3635, 1992
Cytokines, tumour-cell death and immunogenicity: a question of choice
P Musiani, A Modesti, M Giovarelli, F Cavallo, G Forni, PL Lollini, ...
Immunology today 18 (1), 32-36, 1997
Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
M Coscia, E Quaglino, M Iezzi, C Curcio, F Pantaleoni, C Riganti, I Holen, ...
Journal of cellular and molecular medicine 14 (12), 2803-2815, 2010
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor …
A Allione, M Consalvo, P Nanni, PL Lollini, F Cavallo, M Giovarelli, ...
Cancer research 54 (23), 6022-6026, 1994
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and …
M Giovarelli, P Musiani, A Modesti, P Dellabona, G Casorati, A Allione, ...
The Journal of Immunology 155 (6), 3112-3123, 1995
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12
F Cavallo, M Giovarelli, G Forni, P Signorelli, P Musiani, A Modesti, ...
Journal of the National Cancer Institute 89 (14), 1049-1058, 1997
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice
E Quaglino, M Iezzi, C Mastini, A Amici, F Pericle, E Di Carlo, SM Pupa, ...
Cancer Research 64 (8), 2858-2864, 2004
Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12
F Cavallo, E Di Carlo, M Butera, R Verrua, MP Colombo, P Musiani, ...
Cancer research 59 (2), 414-421, 1999
Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response
F Cavallo, A Martin‐Fontecha, M Bellone, S Heltai, E Gatti, P Tornaghi, ...
European journal of immunology 25 (5), 1154-1162, 1995
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten
I Barbieri, S Pensa, T Pannellini, E Quaglino, D Maritano, M Demaria, ...
Cancer research 70 (6), 2558-2567, 2010
p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis
S Cabodi, A Tinnirello, P Di Stefano, B Bisarò, E Ambrosino, I Castellano, ...
Cancer research 66 (9), 4672-4680, 2006
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient …
M Consalvo, CA Mullen, A Modesti, P Musiani, A Allione, F Cavallo, ...
The Journal of Immunology 154 (10), 5302-5312, 1995
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
F Pericle, M Giovarelli, MP Colombo, G Ferrari, P Musiani, A Modesti, ...
The Journal of Immunology 153 (12), 5659-5673, 1994
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
P Musiani, A Allione, A Modica, PL Lollini, M Giovarelli, F Cavallo, ...
Laboratory investigation; a journal of technical methods and pathology 74 (1 …, 1996
The system can't perform the operation now. Try again later.
Articles 1–20